{"id":"https://openalex.org/W4408220105","doi":"https://doi.org/10.1016/j.esmoop.2025.104226","title":"67P LX-101: A novel, clinical stage, payload-bearing targeted therapy directed to the insulin-like growth factor receptor (IGF-1R), demonstrates potent anti-tumor activity in Ewing sarcoma (ES) animal models and desmoplastic small round cell tumor (DSRCT)","display_name":"67P LX-101: A novel, clinical stage, payload-bearing targeted therapy directed to the insulin-like growth factor receptor (IGF-1R), demonstrates potent anti-tumor activity in Ewing sarcoma (ES) animal models and desmoplastic small round cell tumor (DSRCT)","publication_year":2025,"publication_date":"2025-03-01","ids":{"openalex":"https://openalex.org/W4408220105","doi":"https://doi.org/10.1016/j.esmoop.2025.104226"},"language":"en","primary_location":{"id":"doi:10.1016/j.esmoop.2025.104226","doi":"https://doi.org/10.1016/j.esmoop.2025.104226","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2025.104226","pdf_url":"https://www.esmoopen.com/article/S2059-7029(25)00094-8/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.esmoopen.com/article/S2059-7029(25)00094-8/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047440523","display_name":"Matt Hoberman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Hoberman","raw_affiliation_strings":["Operations, Lirum Therapeutics, Inc., New York, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Operations, Lirum Therapeutics, Inc., New York, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030148360","display_name":"Danh D. Truong","orcid":"https://orcid.org/0000-0003-3200-1297","observed_orcids":["https://orcid.org/0000-0003-3200-1297"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D.D. Truong","raw_affiliation_strings":["Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Cardenas Zuniga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Cardenas Zuniga","raw_affiliation_strings":["Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039019183","display_name":"J. Ludwing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Ludwing","raw_affiliation_strings":["Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States of America","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3910,"currency":"USD","value_usd":3910},"apc_paid":{"value":3910,"currency":"USD","value_usd":3910},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":null,"first_page":"104226","last_page":"104226"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.8974999785423279,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.8974999785423279,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.07599999755620956,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-like-growth-factor-receptor","display_name":"insulin-like growth factor receptor","score":0.8550000190734863},{"id":"https://openalex.org/keywords/igf1r-inhibitors","display_name":"IGF1R inhibitors","score":0.9110000133514404},{"id":"https://openalex.org/keywords/ewing-sarcoma","display_name":"Ewing sarcoma","score":0.9409999847412109},{"id":"https://openalex.org/keywords/desmoplastic-small-round-cell-tumor","display_name":"desmoplastic small round cell tumor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6340000033378601},{"id":"https://openalex.org/keywords/gene-fusion","display_name":"gene fusion","score":0.578000009059906},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8420000076293945},{"id":"https://openalex.org/keywords/animal-models","display_name":"animal models","score":0.8970000147819519}],"concepts":[{"id":"https://openalex.org/C2780689927","wikidata":"https://www.wikidata.org/wiki/Q24766801","display_name":"Insulin-like growth factor","level":4,"score":0.6833169460296631},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5869737863540649},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.48965364694595337},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.46506884694099426},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.40931856632232666},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40885359048843384},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.397804319858551},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3509851396083832},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3319186568260193},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10916325449943542}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.esmoop.2025.104226","doi":"https://doi.org/10.1016/j.esmoop.2025.104226","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2025.104226","pdf_url":"https://www.esmoopen.com/article/S2059-7029(25)00094-8/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.esmoop.2025.104226","doi":"https://doi.org/10.1016/j.esmoop.2025.104226","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2025.104226","pdf_url":"https://www.esmoopen.com/article/S2059-7029(25)00094-8/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"},{"id":"https://openalex.org/F4320323383","display_name":"Technische Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/02kkvpp62"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4408220105.pdf","grobid_xml":"https://content.openalex.org/works/W4408220105.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409636856","https://openalex.org/W4392246336","https://openalex.org/W4392888839","https://openalex.org/W7148831107","https://openalex.org/W4409690583","https://openalex.org/W4408220487","https://openalex.org/W4393089469","https://openalex.org/W1993308254","https://openalex.org/W7100770057","https://openalex.org/W7099879616"],"abstract_inverted_index":{"Multiple":[0],"aggressive":[1],"cancers,":[2],"including":[3],"ES":[4],"and":[5,32,47],"DSRCT,":[6],"involve":[7],"alterations":[8],"that":[9],"upregulate":[10],"the":[11],"IGF-1R":[12,20,27],"pathway,":[13],"such":[14],"as":[15],"gene":[16],"fusions":[17],"and/or":[18],"high":[19],"expression,":[21],"correlating":[22],"with":[23],"poor":[24],"outcomes.":[25],"Prior":[26],"inhibitors,":[28],"mainly":[29],"monoclonal":[30],"antibodies":[31],"small":[33],"molecules,":[34],"showed":[35],"some":[36],"tumor":[37],"responses":[38],"but":[39],"weren't":[40],"approved":[41],"potentially":[42],"due":[43],"to":[44,64],"suboptimal":[45],"potency":[46],"escape":[48],"mechanisms":[49],"via":[50],"redundnat":[51],"signaling.":[52],"LX-101,":[53],"a":[54,60,65],"next-generation":[55],"therapy":[56],"targeting":[57],"IGF-1R,":[58],"couples":[59],"proprietary":[61],"IGF-1":[62],"variant":[63],"cytotoxic":[66],"MTX":[67],"payload.":[68]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-03-08T00:00:00"}